[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[H.R. 6218 Introduced in House (IH)]

112th CONGRESS
  2d Session
                                H. R. 6218

      To provide for the establishment of the Autoimmune Diseases 
   Interdepartmental Coordinating Committee, and for other purposes.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                             July 26, 2012

Ms. Buerkle (for herself, Mrs. Maloney, Ms. Lee of California, Mr. King 
   of New York, Mr. Hanna, Mr. Rangel, Mrs. Davis of California, Mr. 
 Turner of New York, Ms. Chu, Mrs. Emerson, Mr. Marino, Mr. Wolf, Mr. 
  Smith of New Jersey, and Mr. Kelly) introduced the following bill; 
       which was referred to the Committee on Energy and Commerce

_______________________________________________________________________

                                 A BILL


 
      To provide for the establishment of the Autoimmune Diseases 
   Interdepartmental Coordinating Committee, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Mary Colella Autoimmune Disease 
Awareness Act of 2012''.

SEC. 2. AUTOIMMUNE DISEASES INTERDEPARTMENTAL COORDINATING COMMITTEE.

    (a) Establishment.--Part B of title III of the Public Health 
Service Act (42 U.S.C. 243 et seq.) is amended by adding at the end the 
following:

``SEC. 320B. AUTOIMMUNE DISEASES INTERDEPARTMENTAL COORDINATING 
              COMMITTEE.

    ``(a) In General.--The Secretary shall establish and maintain a 
committee, to be known as the Autoimmune Diseases Interdepartmental 
Coordinating Committee (referred to in this section as the 
`Coordinating Committee'), for the purpose of formulating 
recommendations for the coordination of governmental and private 
programs and activities relating to autoimmune diseases.
    ``(b) Composition.--The Coordinating Committee shall be composed of 
the following members (or their designees):
            ``(1) The Assistant Secretary for Health, who shall serve 
        as the Chair of the Coordinating Committee.
            ``(2) The Assistant Secretary for Planning and Evaluation.
            ``(3) The Commissioner of Food and Drugs.
            ``(4) The Director of the National Institutes of Health.
            ``(5) The Director of the Centers for Disease Control and 
        Prevention.
            ``(6) The Administrator of the Health Resources and 
        Services Administration.
            ``(7) The Secretary of Education.
            ``(8) The Secretary of Defense.
            ``(9) The Secretary of Veterans Affairs.
            ``(10) The Commissioner of Social Security.
            ``(11) Such other Federal officials as the Secretary may 
        designate or invite, as appropriate, to serve as members on the 
        Coordinating Committee.
    ``(c) Responsibilities.--In furtherance of the purpose described in 
subsection (a), the Coordinating Committee shall--
            ``(1) develop criteria to be used in defining and 
        identifying autoimmune diseases;
            ``(2) monitor Federal, State, and private activities with 
        respect to autoimmune diseases;
            ``(3) make recommendations regarding any appropriate 
        changes to such activities, including recommendations to the 
        Director of NIH with respect to the strategic plan developed 
        under paragraph (5);
            ``(4) make recommendations regarding public participation 
        in decisions relating to autoimmune diseases;
            ``(5) develop and annually update a strategic plan for the 
        coordination of governmental and private programs and 
        activities relating to autoimmune diseases, including--
                    ``(A) proposed budgetary requirements;
                    ``(B) a summary of advances in autoimmune disease 
                research related to causes, prevention, treatment, 
                early screening, diagnosis or rule out, intervention, 
                and access to services and supports for individuals 
                with an autoimmune disease;
                    ``(C) an assessment of research that is being 
                conducted on autoimmune diseases;
                    ``(D) an assessment of the ability of health care 
                providers to identify and diagnose autoimmune diseases 
                properly;
                    ``(E) an assessment of the quality of postgraduate 
                continuing education programs on autoimmune diseases; 
                and
                    ``(F) recommendations on education and continuing 
                education on autoimmune diseases for health care 
                providers; and
            ``(6) on a biennial basis, submit to the Congress such 
        strategic plan and any updates to such plan.
    ``(d) Funding.--
            ``(1) Authorization of appropriations.--To carry out this 
        section, there is authorized to be appropriated $250,000 for 
        each of fiscal years 2013 through 2016.
            ``(2) Funding source.--Funds for carrying out this section 
        shall be derived exclusively from funds made available under 
        section 241.''.
    (b) Conforming Change.--Section 409E of the Public Health Service 
Act (42 U.S.C. 284i) is amended by striking subsection (b).
                                 <all>